An Improved and Scalable Process for Celecoxib: A Selective Cyclooxygenase-2 Inhibitor

被引：24
|
作者：
Reddy, Anumula Raghupathi [2 ]
Sampath, Alla [2 ]
Goverdhan, Gilla [2 ]
Yakambaram, Boja [2 ]
Mukkanti, Kagga [1 ,2 ]
Reddy, Padi Pratap [2 ]
机构：
[1] JNT Univ, Inst Sci & Technol, Ctr Environm Sci, Hyderabad 500072, Andhra Pradesh, India
[2] Dr Reddys Labs Ltd, Dept Res & Dev, Integrated Prod Dev, R R Dist 500072, AP, India
来源：
ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2009年 / 13卷 / 01期
关键词：
COX-2; INHIBITORS; DERIVATIVES; PYRAZOLES; SC-58635;
D O I：
10.1021/op800158w
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
An improved, scalable and commercially viable process is developed for an active pharmaceutical ingredient, celecoxib.
引用
收藏
页码：98 / 101
页数：4
相关论文
共 50 条
  • [1] Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis
    Goldenberg, MM
    CLINICAL THERAPEUTICS, 1999, 21 (09) : 1497 - 1513
  • [2] Effects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats
    Li, Kang-Hua
    Cheng, Liang
    Zhu, Yong
    Deng, Guo-Bing
    Long, Hai-Tao
    INDIAN JOURNAL OF ORTHOPAEDICS, 2013, 47 (04) : 395 - 401
  • [3] Antitumor activity of celecoxib, a selective cyclooxygenase-2 inhibitor, in medullary thyroid carcinoma
    Zhang, Qiang
    Meng, Xianying
    Zheng, Guibin
    Chen, Guang
    Pang, Renzhu
    Hua, Tebo
    Yang, Shuai
    MOLECULAR MEDICINE REPORTS, 2014, 9 (02) : 768 - 772
  • [4] Efficacy and Safety of the Selective Cyclooxygenase-2 Inhibitor Celecoxib in the Treatment of Rheumatoid Arthritis and Osteoarthritis in Japan
    Sakamoto, Choitsu
    Soen, Satoshi
    DIGESTION, 2011, 83 (1-2) : 108 - 123
  • [5] Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
    Dai, Zhi-Jun
    Ma, Xiao-Bin
    Kang, Hua-Feng
    Gao, Jie
    Min, Wei-Li
    Guan, Hai-Tao
    Diao, Yan
    Lu, Wang-Feng
    Wang, Xi-Jing
    CANCER CELL INTERNATIONAL, 2012, 12
  • [6] Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor
    Kalle, Arunasree M.
    Rizvi, Arshad
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (01) : 439 - 442
  • [7] Assessment of the Potential Ototoxicity of High-Dose Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, in Rats
    Li, Bei
    Su, Kaiming
    Yang, Guang
    Feng, Yanmei
    Xia, Li
    Yin, Shankai
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 152 (06) : 1108 - 1112
  • [8] The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II
    Knudsen, JF
    Carlsson, U
    Hammarström, P
    Sokol, GH
    Cantilena, LR
    INFLAMMATION, 2004, 28 (05) : 285 - 290
  • [9] The Cyclooxygenase-2 Inhibitor Celecoxib Is a Potent Inhibitor of Human Carbonic Anhydrase II
    James F. Knudsen
    Uno Carlsson
    Per Hammarström
    Gerald H. Sokol
    Louis R. Cantilena
    Inflammation, 2004, 28 : 285 - 290
  • [10] Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man
    Hinz, Burkhard
    Cheremina, Olga
    Brune, Kay
    FASEB JOURNAL, 2008, 22 (02) : 383 - 390
12345